JEFFREY W. SHERMAN - 10 Jan 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP and Chief Medical Officer
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
10 Jan 2023
Net transactions value
-$761,673
Form type
4
Filing time
12 Jan 2023, 15:29:04 UTC
Previous filing
06 Jan 2023
Next filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Sale $380,752 -3,368 -7.8% $113.05 39,539 10 Jan 2023 Direct F1
transaction HZNP Ordinary Shares Sale $380,921 -3,368 -8.5% $113.10 36,171 11 Jan 2023 Direct F1
holding HZNP Ordinary Shares 49,314 10 Jan 2023 See Footnote F2
holding HZNP Ordinary Shares 84,430 10 Jan 2023 See Footnote F3
holding HZNP Ordinary Shares 66,730 10 Jan 2023 by Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2022.
F2 The shares are held in the Jeffrey W. Sherman Living Trust.
F3 The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.